If you are one of the many women who developed diabetes while taking the statin Lipitor, you may be considering filing a lawsuit to try to recover compensation for the manufacturer’s negligence. Unfortunately, filing and pursuing a lawsuit is a complicated, expensive, and time-consuming proposition. Only by consulting with a qualified attorney can an injured woman ensure that all of the requirements for filing a lawsuit are met, because every case is different, and general information will ...
How Do I File a Lipitor Lawsuit?
Posted September 12, 2014 in Lipitor | Product News and Recalls
Pfizer to Pay $325 Million in Neurontin Settlement
Posted June 6, 2014 in Product News and Recalls | Verdicts & Settlements
Pfizer Inc., manufacturer of Lipitor, Effexor, Zoloft and numerous other medications, has agreed to pay $325 million to resolve a decade-old lawsuit over Neurontin, a drug developed to treat epilepsy. Pfizer was accused of selling the drug without approval by the U.S. Food and Drug Administration and without medical support for its claimed benefits, in an attempt to maximize profits.
This is not ...
continue reading...Pfizer Pays $450 Million to Settle Unlawful Marketing Claims
Posted January 29, 2014 in Product News and Recalls
Patient safety is greatly compromised when financial incentives interfere with crucial medical decisions. The Wall Street Journal reports how two pharmaceutical sales representatives exposed unlawful marketing practices regarding the immunosuppressant drug, Rapamune.
Pfizer and its subsidiary, Wyeth Pharmaceuticals faced a lawsuit under the Federal False Claims Act for actively marketing Rapamune for non-FDA-approved uses as well as paying kickbacks to prescribers.
In paying kickbacks to physicians, pharmaceutical companies manipulate honest and helpful medical advice. This practice could influence a doctor’s ...
continue reading...FDA Warns of Strong Risk of Death with Pfizer’s Drug Tygacil
Posted October 7, 2013 in Drug and Medical Device Lawsuits | Product News and Recalls
The antibacterial drug Tygacil carries a higher risk of death than other drugs of its kind, an article by Reuters reports.
The U.S. Food and Drug Administration issued a safety announcement on September 27, 2013 approving a new Black Box Warning, the strongest warning that can be given to a drug, as well as updated Warnings and Precautions and Adverse Reactions portions of the drug label.
The FDA states on their ...
continue reading...Health warnings issued for cholesterol drugs
Posted September 23, 2013 in Drug and Medical Device Lawsuits | Health | Legal Issues | Lipitor | Product Liability | Product News and Recalls
In a study published in Annals of Internal Medicine, Canadian researchers are advising doctors to avoid ordering certain antibiotics for patients taking the cholesterol-lowering drugs known as statins, which include Lipitor.
An article in U.S. News and World Report says statins don’t mix well with the antibiotics clarithromycin or erythromycin.
This isn’t the first time that health concerns have been raised about statins. The U.S. Food and Drug Administration has added warnings ...
continue reading...Diet changes an option for Lipitor users
Posted July 31, 2013 in Health | Legal Issues | Lipitor | Product Liability | Product News and Recalls
An ABC News report asks the question of whether America is an “overmedicated nation,” and offers alternatives to some of the most commonly prescribed medications.
Among those medications are the anti-cholesterol drugs known as statins. According to the report, the pharmacies fill more than 45 million prescriptions a year for the statin known as Lipitor alone.
But recent research indicates that statins may carry some health risks. The U.S. Food and Drug ...
continue reading...
